Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study

• Main Authors: Dr. Andrew S Azman, PhD (Author), Lucy A Parker, PhD (Author), John Rumunu, MPH (Author), Fisseha Tadesse, MPH (Author), Francesco Grandesso, MPH (Author), Lul L Deng, MD (Author), Richard Laku Lino, MPH (Author), Bior K Bior, PhD (Author), Michael Lasuba, MS (Author), Anne-Laure Page, PhD (Author), Lameck Ontweka, BS (Author), Augusto E Llosa, PhD (Author), Sandra Cohuet, MD (Author), Lorenzo Pezzoli, PhD (Author), Dossou Vincent Sodjinou, MD (Author), Abdinasir Abubakar, MD (Author), Amanda K Debes, PhD (Author), Allan M Mpairwe, MPH (Author), Joseph F Wamala, MPH (Author), Christine Jamet, MPH (Author), Justin Lessler, PhD (Author), Prof. David A Sack, MD (Author), Marie-Laure Quilici, PhD (Author), Iza Ciglenecki, MD (Author), Francisco J Luquero, PhD (Author)
• Format: Book
• Published: Elsevier, 2016-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2-4 weeks between doses. Evidence from previous studies suggests that a single dose of oral cholera vaccine might provide substantial direct protection against cholera. During...